Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance
NCT01690247
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Evidence of Liver Transplantation
Interventions
DRUG:
Conventional plus UC-MSC
DRUG:
Conventional plus placebo
Sponsor
Beijing 302 Hospital